satisfaction

Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

Patients treated with corabotase showed a rapid onset of action of 0.84 days and peak effect statistically superior to placeboAt Week 24, 60.8% of patients treated with corabotase experienced clinically significant sustained duration of effect…

3 days ago

Patients Taking AUSTEDO XR (deutetrabenazine) extended-release tablets Reported Symptom Improvement and High Satisfaction

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®…

8 months ago

Satisfaction of Additional Price Condition and Confirmation of Warrant Expiration Date

August 28, 2025 17:55 ET  | Source: Enovix Corporation Alternate Price Condition of Warrants Satisfied on Thursday, August 28, 2025…

9 months ago